Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/1/2000
 
First Published:
1/1/2000
1.
Phase II Study of ISIS 2503 in Patients With Metastatic and/or Locally Recurrent Adenocarcinoma of the Colon or Rectum (Summary Last Modified 08/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI, Pharmaceutical / Industry
UAB-9860
ISIS-2503-CS6, NCI-G99-1649, NCT00004193
Last Modified:
4/20/2007
 
First Published:
5/1/2000
2.
Phase II Study of ISIS 2503 in Patients With Advanced Adenocarcinoma of the Pancreas (Summary Last Modified 05/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UAB-9915
ISIS-2503-CS5, UAB-F990526011, NCI-G00-1730, NCT00005594
Last Modified:
4/20/2007
 
First Published:
11/1/2000
3.
Phase II Study of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Adenocarcinoma of the Pancreas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NCCTG-N0043
NCT00006467, N0043
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute